Exploring the antifungal potential of novel carbazate derivatives as promising drug candidates against emerging superbug, Candida auris

被引:0
|
作者
Fatima, Tazeen [1 ]
Fatima, Zeeshan [1 ]
Billamboz, Muriel [2 ]
Hameed, Saif [1 ]
机构
[1] Amity Univ Haryana, Amity Inst Biotechnol, Gurgaon 122413, India
[2] Univ Catholique Lille, ICL, JUNIA, LITL, F-59000 Lille, France
关键词
Efflux pump; Ergosterol; Oxidative stress; Biofilm; C; elegans; ABC TRANSPORTER; ALBICANS; FLUCONAZOLE; RESISTANCE; ERGOSTEROL; EFFLUX; BIFENAZATE; TARGETS; GROWTH; MODE;
D O I
10.1016/j.bioorg.2024.107782
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Candida auris (C. auris) has caused notable outbreaks across the globe in last decade and emerged as a lifethreatening human pathogenic fungus. Despite significant advances in antifungal research, the drug resistance mechanisms in C. auris still remain elusive. Under such pressing circumstances, research on identification of new antifungal compounds is of immense interest. Thus, our studies aimed at identifying novel drug candidates and elucidate their biological targets in C. auris. After screening of several series of synthetic and hemisynthetic compounds from JUNIA chemical library, compounds C4 (butyl 2-(4-chlorophenyl)hydrazine-1-carboxylate) and C13 (phenyl 2-(4-chlorophenyl) hydrazine-1-carboxylate), belonging to the carbazate series, were identified to display considerable antifungal activities against C. auris as well as its fluconazole resistant isolates. Elucidation of biological targets revealed that C4 and C13 lead to changes in polysaccharide composition of the cell wall and disrupt vacuole homeostasis. Mechanistic insights further unravelled inhibited efflux pump activities of ATP binding cassette transporters and depleted ergosterol content. Additionally, C4 and C13 cause mitochondrial dysfunction and confer oxidative stress. Furthermore, both C4 and C13 impair biofilm formation in C. auris. The in vivo efficacy of C4 and C13 were demonstrated in Caenorhabditis elegans model after C. auris infection showing reduced mortality of the nematodes. Together, promising antifungal properties were observed for C4 and C13 against C. auris that warrant further investigations. To summarise, collected data pave the way for the design and development of future first-in-class antifungal drugs.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Efficacy of Novel Schiff base Derivatives as Antifungal Compounds in Combination with Approved Drugs Against Candida Albicans
    Malik, Manzoor Ahmad
    Lone, Shabir Ahmad
    Gull, Parveez
    Dar, Ovas Ahmad
    Wani, Molumnad Younus
    Ahmad, Aijaz
    Hashmi, Athar Adil
    MEDICINAL CHEMISTRY, 2019, 15 (06) : 648 - 658
  • [42] Synthesis, Cytotoxicity Evaluation, and Antifungal Activity of Novel Nitroglycerin Derivatives against Clinical Candida albicans Isolates
    Rashidi, Niloofar
    Rezaie, Sassan
    Hashemi, Sayed Jamal
    Habibi, Aziziollah
    Baghersad, Mohammad Hadi
    Daie, Roshanak
    Khodavaisy, Sadegh
    Bakhshi, Heidar
    Salimi, Ali
    Getso, Mohammad Ebraim
    Rafat, Zahra
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2021, 50 (09) : 1872 - 1881
  • [43] Functional Characterization of a Bacillus-Derived Novel Broad-Spectrum Antifungal Lipopeptide Variant against Candida tropicalis and Candida auris and Unravelling Its Mode of Action
    Ramesh, Swetha
    Madduri, Madhuri
    Rudramurthy, Shivaprakash M.
    Roy, Utpal
    MICROBIOLOGY SPECTRUM, 2023, 11 (02):
  • [44] The Neosartorya fischeri Antifungal Protein 2 (NFAP2): A New Potential Weapon against Multidrug-Resistant Candida auris Biofilms
    Kovacs, Renato
    Nagy, Fruzsina
    Toth, Zoltan
    Forgacs, Lajos
    Toth, Liliana
    Varadi, Gyorgyi
    Toth, Gabor K.
    Vadaszi, Karina
    Borman, Andrew M.
    Majoros, Laszlo
    Galgoczy, Laszlo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (02) : 1 - 14
  • [45] Ligand-based analysis of the antifungal potential of phytosterols and triterpenes isolated from Cryptostegia grandiflora against Candida auris FKBP12
    Belarmino, Anthony Barbosa
    de Sousa, Damia Sampaio
    Roberto, Caio Henrique Alexandre
    de Oliveira, Victor Moreira
    da Rocha, Matheus Nunes
    Mendes, Francisco Rogenio da Silva
    Marinho, Marcia Machado
    da Fonseca, Aluisio Marques
    Marinho, Gabrielle Silva
    STEROIDS, 2024, 209
  • [46] Antifungal evaluation of quinoline-chalcone derivatives combined with FLC against drug-resistant Candida albicans
    Chai, Nannan
    Sun, Aimei
    Zhu, Xianhu
    Li, Yanping
    Wang, Ruirui
    Zhang, Yi
    Mao, Zewei
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 86
  • [47] Screening of the global health priority Box® reveals potential new disinfectants against the emerging multidrug-resistant pathogen Candida auris
    Retore, Yasmim Isabel
    Lucini, Fabiola
    Pimentel, Larissa Rodrigues
    de Oliveira, Haroldo Cesar
    Simionatto, Simone
    Rossato, Luana
    MICROBIAL PATHOGENESIS, 2024, 194
  • [48] Antifungal activity of clinical Lactobacillus strains against Candida albicans biofilms: identification of potential probiotic candidates to prevent oral candidiasis
    Rossoni, Rodnei Dennis
    de Barros, Patricia Pimentel
    de Alvarenga, Janaina Araujo
    Ribeiro, Felipe de Camargo
    Velloso, Marisol dos Santos
    Fuchs, Beth Burgwyn
    Mylonakis, Eleftherios
    Cardoso Jorge, Antonio Olavo
    Junqueira, Juliana Campos
    BIOFOULING, 2018, 34 (02) : 212 - 225
  • [49] Identification and structural investigation of potential novel drug candidates against lethal human pathogen
    Hamid, Mehwish
    Aurangzeb, Sana
    Rashid, Yasmeen
    Khan, Khalid Mohammed
    Hameed, Abdul
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 34 (01) : 21 - 34
  • [50] Exploring Novel Drug Combinations: The Therapeutic Potential of Selanyl Derivatives for Leishmania Treatment
    Henriquez-Figuereo, Andreina
    Moreno, Esther
    Sanmartin, Carmen
    Plano, Daniel
    MOLECULES, 2023, 28 (15):